;){kind=link}
Mr. Michael
Sales Manager
Foreign Trade Department
Address:
No. 99 Baoan Road, Limin Development Zone, Songbei District, Harbin, Heilongjiang, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2022
Business Range:
Chemicals, Health & Medicine, Service
Management System Certification:
ISO 9001, ISO 14000, GMP
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province ...
We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province ...
Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province Innovation Center of Synthetic Peptide, Harbin Enterprise Technology Center. As well as a initiating and governing unit of Polypeptide Branch of China Biochemical and Pharmaceutical Industry Association.
Founded in 2011, located in Harbin China. With registered capital 17.4291 million, covering an area of 23, 000 square meters, construction area 4, 000 square meters.
Jixianglong has peptide drug production workshop and pilot workshop for neoantigen personalized tumor peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Principal Business:
-API Production
-API R&D technical support
-Preparation R&D Technical support
-Custom peptide service
-Solid phase synthesizer production
-Production of neoantigen personalized tumor polypeptide vaccine
-Cosmetic peptide production & sales
-Medical devices production & sales
-Disinfection products production & sales
Main Products:
10 items completed polypeptide API declared:
Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate.
N items as researching reserve series:
Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Anti peptide bacteriostatic spray, Peptide drug conjugate (PDC)
We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province Innovation Center of Synthetic Peptide, Harbin Enterprise Technology Center. As well as a initiating and governing unit of Polypeptide Branch of China Biochemical and Pharmaceutical Industry Association.
Founded in 2011, located in Harbin China. With registered capital 17.4291 million, covering an area of 23, 000 square meters, construction area 4, 000 square meters.
Jixianglong has peptide drug production workshop and pilot workshop for neoantigen personalized tumor peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Principal Business:
-API Production
-API R&D technical support
-Preparation R&D Technical support
-Custom peptide service
-Solid phase synthesizer production
-Production of neoantigen personalized tumor polypeptide vaccine
-Cosmetic peptide production & sales
-Medical devices production & sales
-Disinfection products production & sales
Main Products:
10 items completed polypeptide API declared:
Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate.
N items as researching reserve series:
Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Anti peptide bacteriostatic spray, Peptide drug conjugate (PDC)
International Commercial Terms(Incoterms):
FOB, EXW, CFR, CIF, DDP
Terms of Payment:
LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram
Average Lead Time:
Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays
Number of Foreign Trading Staff:
4~10 People
Export Year:
2022-03-17
Export Percentage:
>90%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Nearest Port:
Dalian
Factory Address:
No. 99 Baoan Road, Limin Development Zone, Songbei District, Harbin, Heilongjiang, China
R&D Capacity:
OEM, ODM, Own Brand(JXL)
No. of R&D Staff:
5-10 People
No. of Production Lines:
5
Annual Output Value:
Above US$100 Million